GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.46
−5.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.52x
- Price / sales
- 26.39x
- Price / cash flow
- -1.34x
Enterprise value
- Enterprise value
- $8.7M
- EV / sales
- 44.60x
- EV / EBITDA
- -2.35x
- EV / EBIT
- -1.97x
- Market cap
- $5.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025